1. Market Research
  2. > Pathology
About 200 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Pharmaceutical Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Route of Administration ; Application ; End User, and Geography

  • $ 4550
  • May 2020
  • 197 pages

Pfizer Inc. has received the European Commission (EC) for its Lorviqua for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive advanced nonsmall cell lung cancer (NSCLC).

  • Diabetes
  • Lymphoma
  • Pharmaceutical
  • Forecast
  • Market Size

Global Clinical Chemistry Analyzer Market - Opportunities and Forecast (2013-2023)

  • $ 2200
  • March 2019
  • 220 pages

NORTH AMERICA CLINICAL CHEMISTRY ANALYZER MARKET FIGURE ##: NUMBER OF PEOPLE LIVING WITH BLOOD CANCER IN CANADA, 2016 Forms of Blood Cancer Number of Patients Lymphoma ##, ## Leukemia ##, ## Myeloma ##, ## Myelodysplastic Syndromes ##, ## Polycythemia Vera ##, ## Thrombocythemia ##, ## Myelof

  • Clinical Chemistry
  • Diabetes
  • In Vitro Diagnostics
  • Lymphoma
  • World

Global Autoimmune Disease Diagnostic Market (By Disease, Tests Type, Regions), Key Company Profiles - Forecast to 2026

  • $ 1890
  • November 2019
  • 137 pages

lymphoma, metabolic disorders, obesity, occult blood testing, ophthalmology, osteoporosis, pancreatitis, respiratory disorders, rheumatoid arthritis, sepsis, sexually transmitted infections, skin cancer, transplantation, tuberculosis, urinary tract infections, and West Nile virus diseases.

  • Autoimmune Disease
  • Diabetes
  • Diagnostics
  • Lymphoma
  • World

Global Cell Expansion Market: Analysis By Product Type, Cell Type, By Application, By Region, By Country : Opportunities and Forecast – By Application, By Region, By Country

  • $ 2400
  • June 2019
  • 284 pages

Lymphoma ##, ## Leukemia ##, ## Myeloma ##, ## Myelodysplastic Syndromes ##, ## Polycythemia Vera ##, ## Thrombocythemia ##, ## Myelofibrosis ##, ## Forms of Blood Cancer Number of Patients Source: LLS Canada FIGURE ##: NUMBER OF BLOOD CANCER CASES IN UNITED STATES, 2018 (c) Azoth Analytics To

  • Diabetes
  • Healthcare
  • Insulin Delivery
  • Lymphoma
  • World

Global Compounding Pharmacies Market - Opportunities and Forecast (2014-2024)

  • $ 2400
  • July 2019
  • 260 pages

Compounding Pharmacies Market: World Market Analysis By Product Type, By Therapeutic Area, By End User, By Region, By Country (2019 Edition): Forecast to 2024 Dermatology and Others) India, Brazil and Mexico.

  • Diabetes
  • Lymphoma
  • Pharmacy
  • World
  • Market Size

Global Regenerative Medicine Market - Opportunities and Forecast

  • $ 2400
  • August 2019
  • 326 pages

This strategic acquisition will further promote Gilead as an industry leader in refractory large B-cell lymphoma after two or more lines of therapy.

  • Biopharmaceutical
  • Diabetes
  • Lymphoma
  • Regenerative Medicine
  • Market Size

Wearable Injectors Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type ; Application ; End User ; and Geography

  • $ 4550
  • June 2020
  • 184 pages

The wearable injectors market was valued at US$ 5,791.23 million in 2019 and is projected to reach US$ 13,880.88 million by 2027; it is expected to grow at a CAGR of 11.6% during 2020-2027. Wearable injectors ...

  • Autoimmune Disease
  • Diabetes
  • Lymphoma
  • United States
  • Forecast

North America Pharmaceutical Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By  Route of Administration ; Application ; End User ; and Country

  • $ 3000
  • June 2020
  • 145 pages

Pfizer Inc. has received the European Commission (EC) for its Lorviqua for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC).

  • Diabetes
  • Lymphoma
  • Pharmaceutical
  • North America
  • United States

Global Sterile Injectables Market – Analysis By Molecule Type, Drug Type, Indication, Distribution Channel, By Region, By Country (2018 Edition): Forecast to 2023 - Molecule Type, Drug Type, Indication, Channel

  • $ 2400
  • June 2018
  • 240 pages

lymphoma Diffuse large B-cell lymphoma Diffuse large B-cell lymphoma Pfizer Utomilumab Human IgG## CD## Phase ## Hoffmann-La Roche Polatuzumab vedotin Humanized IgG## ADC CD##b Phase ## Viventia Bio Oportuzumab monatox Humanized scFv immunotoxin EpCAM Phase ## Bladder cancer S

  • Diabetes
  • Endocrine Disease
  • Lymphoma
  • World
  • Baxter International Inc.

Europe Pharmaceutical Drug Delivery Market Forecast to 2027 - Covid-19 Impact and Regional Analysis By  Route of Administration ; Application ; End User ; and Country

  • $ 3000
  • June 2020
  • 145 pages

Novartis has received the US Food and Drug Administration (FDA) approved for the Zykadia, which is used for the treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)positive.

  • Diabetes
  • Lymphoma
  • Pharmaceutical
  • Forecast
  • GlaxoSmithKline plc

Clinical Nutrition Market - Global Outlook and Forecast 2020-2025

  • $ 3500
  • July 2020
  • 306 pages

The most common categories of cancers in children include leukemias, brain cancers, lymphomas, and solid tumors such as neuroblastoma and Wilms' tumor.

  • Clinical Nutrition
  • Diabetes
  • Lymphoma
  • Pharmaceutical
  • World

Vascular Access Device Market: World Market - Opportunities and Forecast (2014-2024)

  • $ 2400
  • July 2019
  • 300 pages

Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the ...

  • Diabetes
  • Drug Delivery
  • Injectable Delivery
  • Lymphoma
  • World

Vanderbilt University Medical Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • September 2018
  • 56 pages

The institute' s target therapy areas include leukemia, lymphoma, blood cancer, lung cancer, breast cancer, colorectal cancer and skin cancer, among others.

  • Ambulatory Care
  • Diabetes
  • Lymphoma
  • Therapy
  • United States

Global Diabetes Drugs Market to 2023 - A Diversifying Treatment Landscape as GLP-1 Receptor Agonists and SGLT-2 Inhibitors Gain Ground Following Landmark Cardiac Outcomes

  • $ 4995
  • September 2017
  • 137 pages

Numerous intracellular substrates such as insulin receptor substrate (IRS) proteins, casitas B-lineage lymphoma (CBL), adapter proteins with a pleckstrin homology (PH) and Src Homology ## (SH##) domain and GRB##-associated-binding protein ## (GAB##) are activated upon binding of the insulin rece

  • Chronic Disease
  • Clinical Trial
  • Diabetes
  • Insulin
  • Lymphoma

Blood Glucose (SMBG) (Test Strips, Lancet, Meter) Market and Forecast - Global Analysis

  • $ 1690
  • March 2017
  • 376 pages

lymphoma, metabolic disorders, obesity, occult blood testing, ophthalmology, osteoporosis, pancreatitis, respiratory disorders, rheumatoid arthritis, sepsis, sexually transmitted infections, skin cancer, transplantation, tuberculosis, urinary tract infections, and west nile virus diseases.

  • Diabetes
  • Diabetes Monitoring
  • Lymphoma
  • Patient Monitoring
  • Forecast

Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2023 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth

  • $ 4995
  • October 2017
  • 202 pages

IT IS THOUGHT THAT METFORMIN STIMULATES AMPK TO PHOSPHORYLATE CASITAS B-LINEAGE LYMPHOMA (CBL) AND INDUCE CBL ASSOCIATED PROTEIN (CAP) EXPRESSION.

  • Diabetes
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Novo Nordisk Group

Regenerative Medicine Market by Type, Applications, Region - Global Forecast to 2024

  • $ 4950
  • March 2019
  • 108 pages

The cell-based immunotherapy & cell therapy products segment is further segmented into allogeneic Kite Pharma/ Gilead (US) Cell-based immunotherapy (CAR T-cell therapy) Treatment of B-cell malignancies such as non-Hodgkin lymphoma, acute lymphoblastic leukemia, mantle cell

  • Cell Therapy
  • Diabetes
  • Lymphoma
  • Regenerative Medicine
  • United States

Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment

  • $ 4995
  • August 2016
  • 1 pages

Numerous intracellular substrates such as insulin receptor substrate (IRS) proteins, Casitas B-lineage Lymphoma (CBL), adapter proteins with a PH and SH## domain (APS and Shc), and GRB##-associated-binding protein ## (GAB##) are activated and, in turn, lead to the activation of downstream signa

  • Diabetes
  • Lymphoma
  • Obesity
  • Therapy
  • Eli Lilly & Co.

Analyzing the Global Diabetes Market 2016

  • $ 1000
  • September 2016
  • 195 pages

IN FEBRUARY 2015, THE COMPANY DISCONTINUED SAR-##, WHICH WAS IN PHASE I TRIAL FOR THE TREATMENT OF ADVANCED SOLID TUMORS OR LYMPHOMAS, METASTATIC BRAF-MUTATED MELANOMA AND PTEN DEFICIENT TUMORS.

  • Antidiabetics
  • Diabetes
  • Insulin
  • Lymphoma
  • United States

Biosimilars Market by Product, Manufacturing & Indication, Region – Global Forecast to 2025

  • $ 4950
  • March 2020
  • 187 pages

LYMPHOMA GENERICS AND BIOSIMILARS INITIATIVE GRANULOCYTE COLONY-STIMULATING FACTORS GENERIC PHARMACEUTICAL ASSOCIATION GLAXOSMITHKLINE HOSPITAL-ONLY MEDICINES INTERNATIONAL FEDERATION OF PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS PHARMACEUTICAL AND MEDICAL DEVICE AGENCY ONCOLOGIC DRUGS

  • Biosimilar
  • Diabetes
  • Lymphoma
  • North America
  • United States
View report >

Asthma Statistics in the UK

  • January 2017
  • 15 pages

Cancer Chart ##. ## shows the most common cancers for this age group are lymphomas, including cancer of the lymph system, Hodgkin Disease and non-Hodgkin Lymphoma, followed by carcinomas (malignant tumours on the surface or lining of a body organ).

  • Asthma
  • Diabetes
  • Lymphoma
  • United Kingdom
  • Diabetes UK

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on